Ostabolin topical - Zelos Therapeutics

Drug Profile

Ostabolin topical - Zelos Therapeutics

Alternative Names: Cyclic hPTH-(1-31)-NH2 topical; Ostabolin-C gel; Parathyroid hormone analogue topical - Zelos Therapeutics

Latest Information Update: 13 Oct 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Zelos Therapeutics Inc
  • Class Osteoporosis therapies; Peptide fragments; Peptide hormones
  • Mechanism of Action Calcitriol receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Psoriasis

Most Recent Events

  • 09 Feb 2006 Zelos Therapeutics Inc. has completed enrolment in a phase II trial for Psoriasis in Canada
  • 31 Aug 2005 Phase-II clinical trials in Psoriasis in Canada (Topical)
  • 30 Jun 2005 Phase-I clinical trials in Psoriasis in Canada (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top